• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然周期体外受精联合未成熟卵母细胞体外成熟患者的选择。

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes.

作者信息

Lim Jin-Ho, Yang Seong-Ho, Xu Ye, Yoon San-Hyun, Chian Ri-Cheng

机构信息

Maria Fertility Hospital, Seoul, South Korea.

出版信息

Fertil Steril. 2009 Apr;91(4):1050-5. doi: 10.1016/j.fertnstert.2008.01.066. Epub 2008 Mar 25.

DOI:10.1016/j.fertnstert.2008.01.066
PMID:18367180
Abstract

OBJECTIVE

To determine a successful method of selecting patients for natural cycle IVF combined with in vitro maturation (IVM) of immature oocytes and to determine treatment efficacy.

DESIGN

Retrospective analysis of IVF treatments.

SETTING

Hospital IVF clinic.

PATIENT(S): Women with infertility according to ovarian reserve and endocrine profile were selected for different treatments.

INTERVENTIONS(S): According to screening criteria, infertile women were divided into three treatments: [1] natural cycle IVF combined with IVM (IVF/M), [2] IVM alone, and [3] controlled ovarian hyperstimulation (COH) with gonadotropin.

MAIN OUTCOME MEASURE(S): The distribution of completed IVF-ET cycles in each treatment; clinical pregnancy and implantation rates in each treatment.

RESULT(S): A total of 417 cycles were started, and 410 cycles (98.3%) were completed. Of 410 cycles, 151 (36.8%) were treated by natural cycle IVF/M, 63 (15.4%) underwent IVM alone, and 196 (47.8%) underwent COH. With increasing age fewer cycles can be treated by natural cycle IVF/M or IVM. Clinical pregnancy rates were 40.4% (61 of 151) for natural cycle IVF/M, 41.3% (26 of 63) for IVM alone, and 37.8% (74 of 196) for COH. There were no differences in implantation rate in the three groups (17.8% [82 of 462], 16.7% [35 of 210], and 20.1% [103 of 513]).

CONCLUSION(S): Natural cycle IVF/M together with IVM-alone treatment can offer more than 50% of infertile women with an acceptable pregnancy and implantations rates.

摘要

目的

确定一种成功的方法来选择适合自然周期体外受精(IVF)联合未成熟卵母细胞体外成熟(IVM)的患者,并确定治疗效果。

设计

对IVF治疗进行回顾性分析。

地点

医院IVF诊所。

患者

根据卵巢储备和内分泌情况选择患有不孕症的女性进行不同治疗。

干预措施

根据筛选标准,将不孕女性分为三种治疗方式:[1]自然周期IVF联合IVM(IVF/M),[2]单纯IVM,[3]使用促性腺激素进行控制性卵巢刺激(COH)。

主要观察指标

每种治疗中完成的IVF-ET周期分布;每种治疗的临床妊娠率和着床率。

结果

共启动417个周期,410个周期(98.3%)完成。在410个周期中,151个(36.8%)接受自然周期IVF/M治疗,63个(15.4%)单纯接受IVM治疗,196个(47.8%)接受COH治疗。随着年龄增长,自然周期IVF/M或IVM能治疗的周期数减少。自然周期IVF/M的临床妊娠率为40.4%(151例中的61例),单纯IVM为41.3%(63例中的26例),COH为37.8%(196例中的74例)。三组的着床率无差异(分别为17.8%[462例中的82例]、16.7%[210例中的35例]和20.1%[513例中的103例])。

结论

自然周期IVF/M联合单纯IVM治疗可为超过50%的不孕女性提供可接受的妊娠率和着床率。

相似文献

1
Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes.自然周期体外受精联合未成熟卵母细胞体外成熟患者的选择。
Fertil Steril. 2009 Apr;91(4):1050-5. doi: 10.1016/j.fertnstert.2008.01.066. Epub 2008 Mar 25.
2
[In vitro maturation and fertilization of unstimulated immature oocyte for the treatment of infertile women].未刺激的未成熟卵母细胞体外成熟与受精用于治疗不孕女性
Zhonghua Fu Chan Ke Za Zhi. 2006 Mar;41(3):173-6.
3
Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.自然周期体外受精联合未成熟卵母细胞体外成熟是不孕症治疗的一种潜在方法。
Fertil Steril. 2004 Dec;82(6):1675-8. doi: 10.1016/j.fertnstert.2004.04.060.
4
Influence of well defined protein source on in vitro maturation of human oocyte: human follicular fluid versus human serum albumin.明确的蛋白质来源对人卵母细胞体外成熟的影响:人卵泡液与人血清白蛋白的比较
Fertil Steril. 2008 Feb;89(2):348-52. doi: 10.1016/j.fertnstert.2007.02.052. Epub 2007 May 7.
5
In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities".因“卵母细胞成熟异常”导致反复体外受精失败患者的体外成熟培养。
Fertil Steril. 2010 Jul;94(2):496-501. doi: 10.1016/j.fertnstert.2009.03.040. Epub 2009 Jul 8.
6
Pregnancies and deliveries after transfer of human blastocysts derived from in vitro matured oocytes in in vitro maturation cycles.体外成熟周期中源自体外成熟卵母细胞的人囊胚移植后的妊娠与分娩
Fertil Steril. 2007 Jun;87(6):1491-3. doi: 10.1016/j.fertnstert.2006.11.027. Epub 2007 Feb 12.
7
The in vitro maturation (IVM) of human oocytes for in vitro fertilization (IVF): is it time yet to switch to IVM-IVF?用于体外受精(IVF)的人类卵母细胞体外成熟(IVM):是时候转向IVM-IVF了吗?
Fertil Steril. 2006 Apr;85(4):833-5; discussion 841. doi: 10.1016/j.fertnstert.2005.08.069.
8
[In vitro maturation of human egg cells. Introduction of a new artificial reproduction technique in the Netherlands].[人类卵细胞的体外成熟。荷兰一项新的人工生殖技术的引入]
Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):82-6.
9
Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients.未刺激患者体外成熟卵母细胞授精后获得良好妊娠结局。
Hum Reprod. 2005 Jun;20(6):1534-40. doi: 10.1093/humrep/deh768. Epub 2005 Feb 3.
10
Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.在体外成熟过程中暴露于人类绒毛膜促性腺激素并不能提高多囊卵巢综合征患者未成熟卵母细胞的成熟率和发育潜能。
Fertil Steril. 2008 Jan;89(1):98-103. doi: 10.1016/j.fertnstert.2007.02.021. Epub 2007 May 24.

引用本文的文献

1
The quality of human eggs and its pre-IVF incubation.人类卵子的质量及其体外受精前培养
Reprod Med Biol. 2025 May 2;24(1):e12652. doi: 10.1002/rmb2.12652. eCollection 2025 Jan-Dec.
2
Current status and hotspots of in vitro oocyte maturation: a bibliometric study of the past two decades.体外卵母细胞成熟的现状与热点:一项过去二十年的文献计量学研究
J Assist Reprod Genet. 2025 Feb;42(2):459-472. doi: 10.1007/s10815-024-03272-w. Epub 2024 Sep 25.
3
IVM of human immature oocytes for infertility treatment and fertility preservation.
人类未成熟卵母细胞的体外成熟用于不孕症治疗和生育力保存。
Reprod Med Biol. 2023 Jul 11;22(1):e12524. doi: 10.1002/rmb2.12524. eCollection 2023 Jan-Dec.
4
Effects of different sperm sources on the clinical outcomes of oocyte maturation cycles combined with intracytoplasmic sperm injection.不同精子来源对卵母细胞成熟周期结合胞浆内单精子注射治疗临床结局的影响。
Front Endocrinol (Lausanne). 2023 Feb 20;14:1115210. doi: 10.3389/fendo.2023.1115210. eCollection 2023.
5
Effect of dominant follicle status at the time of retrieval on the clinical outcomes in natural cycle IVF combined with immature oocyte treatment.在自然周期 IVF 结合未成熟卵母细胞治疗中,取卵时主导卵泡状态对临床结局的影响。
Aging (Albany NY). 2022 Jun 7;14(11):4728-4738. doi: 10.18632/aging.204106.
6
Stem Cell Therapies for Human Infertility: Advantages and Challenges.干细胞疗法治疗人类不孕:优势与挑战。
Cell Transplant. 2022 Jan-Dec;31:9636897221083252. doi: 10.1177/09636897221083252.
7
The flip side of the coin: is the endometrium ready for IVM-derived embryo implantation?问题的另一面:子宫内膜是否准备好接受体外成熟(IVM)获得的胚胎着床?
J Assist Reprod Genet. 2021 Jun;38(6):1289-1291. doi: 10.1007/s10815-021-02239-5. Epub 2021 Jun 21.
8
The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.抗缪勒管激素(AMH)在卵巢疾病和不孕中的作用。
J Assist Reprod Genet. 2020 Jan;37(1):89-100. doi: 10.1007/s10815-019-01622-7. Epub 2019 Nov 21.
9
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.多囊卵巢综合征不孕妇女在接受辅助生殖时的体外成熟。
Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD006606. doi: 10.1002/14651858.CD006606.pub4.
10
In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report.体外成熟可能预防低反应患者体外受精周期的取消:一例报告。
J Turk Ger Gynecol Assoc. 2013 Jul 10;14(4):235-7. doi: 10.5152/jtgga.2013.68335. eCollection 2013.